Latest posts tagged with #ESMOguidelines on Bluesky
The next #ESMOGuidelines webinar focuses on #GastroesophagealCancer β from biomarker testing to immunotherapy integration.
π Live Q&A with expert faculty
π Earn 1 ESMO-MORA Cat. 1 point
π Open to all with an ESMO account
π Join us: https://ow.ly/SU2g50YlJnP
#ESMOOnAir #ESMOWebinars
π£Updated ESMO #ClinicalPracticeGuideline on advanced and metastatic #ProstateCancer:
β
Substantial advances in castration-sensitive & -resistant prostate cancer
β
Updated algorithms & recommendations reflecting latest clinical data
#ESMOGuidelines Christopher Sweeney
π https://ow.ly/E4ov50Yc8e2
π£ESMO #ClinicalPracticeGuideline Express Update on #EpithelialOvarianCancer:
- Rucaparib: 1st-line PARPi maintenance option
- MIRV: for recurrent FRΞ±-high #OvarianCancer after 1-3 prior therapies & PFI <6 months
π https://ow.ly/J06u50Y4HT8
#GYNOnc #Oncology #ESMOGuidelines
π£ ESMO #ClinicalPracticeGuideline Express Update on Localised #ColonCancer: π‘CHALLENGE trial suggests survival benefits from structured exercise
π₯Selected resected patients to be informed & encouraged to participate #Oncology #ESMOGuidelines
π https://ow.ly/lJY850Y49fR
π Join us for the #ESMOGuidelines webinar to get practical insights on ctDNA, NGS, MSIβH/dMMR and targeted treatments to support personalised #CRC care.
Open to all ESMO account holders.
πRegister here: https://ow.ly/kE7S50Y1Ljw
#ESMOWebinar #ESMOOnAir #CancerGuidelines
π£ Updated ESMO #ClinicalPracticeGuideline on local & locoregional #ProstateCancer:
β
New imaging modalities: Improved diagnosis, staging & risk stratification
β
Updated algorithms: less over-Tx & fewer side-effects
#Oncology #UroOncology #CancerCare #ESMOGuidelines
π https://ow.ly/jwA650XLs1q
π Innovation is reshaping #prostatecancer care! Explore new therapies, imaging & evidence-based strategies in the #ESMOGuidelines webinar
π Free with your ESMO account: https://ow.ly/RN1E50XAug9
#ESMOWebinars #ESMOOnAir
π Join the upcoming #ESMOGuidelines Webinar to explore #realworldcases, expert insights & the latest treatment strategies in #lymphoma
π Free with your ESMO account: https://ow.ly/xaKa50XuGaW
π ESMO Clinical Practice Guidelines at #ESMO25 #ESMOGuidelines
Session I: HCC & melanoma
π
19 Oct | 10:15β11:45 | Hall 7.1c
Session II: Lymphomas & early-stage NSCLC
π
19 Oct | 14:45β16:15 | Hall 7.1c
π buff.ly/h4FL2cU
π£ New ESMO #Lymphomas Living Guideline v1.0.
Includes all recommendations and algorithms from the published #ClinicalPracticeGuideline, covering major lymphoma subtypes in an interactive format.
π https://ow.ly/wLFE50X7y9e
#ESMOGuidelines
π Join the upcoming #ESMOGuidelines Webinar to explore #realworldcases, expert insights & the latest treatment strategies in #melanoma
π Free with your ESMO account: buff.ly/Q783hIx
π£ Updated ESMO #ClinicalPracticeGuideline on early & locally advanced #NSCLC: new systemic treatments, innovative strategies & advanced therapeutic options to personalise #PatientCare & improve outcomes.
π buff.ly/Yn640wo
#LungCancer #SystemicTherapy #Oncology #CancerTreatment #ESMOGuidelines
π£Updated ESMO #ClinicalPracticeGuideline recommendations in #MetastaticBreastCancer: focusing on #PrecisionOncology and a #PatientCentricCare, this commentary highlights key updates of the ESMO Living Guideline algorithms, focusing on HR+/HER2- disease. #ESMOGuidelines
π buff.ly/fvvPb26
π£ New ESMO #ClinicalPracticeGuideline on #lymphomas: evidence-based recommendations for all major #lymphoma subtypes, updated as needed as an ESMO Living Guideline, reflecting developments in Tx.
#DLBCL #PCNSL #FollicularLymphoma #HodgkinLymphoma #ESMOGuidelines
π buff.ly/2ZYJc2c
π£ ESMO Living Guidelines on Metastatic Colorectal Cancer v1.3: Updated recommendations and algorithms for the treatment of patient with BRAF-mut.
π buff.ly/hlp0K4S
#ESMOGuidelines
π ESMO Living Guidelines on Localised Rectal Cancer: New title in the library with all recommendations and algorithms from the published Guideline in an interactive format.
#ESMOGuidelines
π buff.ly/WFIOLUJ
π£Updated ESMO #ClinicalPracticeGuideline recommendations in oncogene-addicted metastatic #NSCLC: more #TargetedTherapy agents now available in 1L or at resistance.
#LungCancer #mNSCLC #ESMOGuidelines
π buff.ly/DSLyGib
π£Updated ESMO #ClinicalPracticeGuideline recommendations in the non-oncogene-addicted metastatic #NSCLC: new 1L Tx options approved.
π buff.ly/da21Bml
#LungCancer #mNSCLC #ESMOGuidelines
ESMO Guidelines: Real World Cases - Webinar Series: Metastatic Breast Cancer 2025
@myesmo.bsky.social
oncodaily.com/blog/esmo-gu...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMOGuidelines #BreastCancer #mBC
π Stay up to date with the latest evidence-based recommendations from the #ESMOGuidelines for the treatment of metastatic #breastcancer to optimise patient outcomes.
Join this live discussion and submit your questions
π buff.ly/nj2nMtC
π£ Updated ESMO #ClinicalPracticeGuideline on #localised #rectalcancer: situation-dependent intensification & de-intensification, complex radiological factors, #biomarkers & selective Tx goals via organ-preserving strategies form options & decisions
#ESMOGuidelines
π buff.ly/GPnKSMY
π£ Updated ESMO-EHA #ClinicalPracticeGuideline on management of βmatureβ or βperipheralβ T- and NK-cell #lymphomas: π clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up.
π buff.ly/dvDOsNK
@hemasphere-journal.bsky.social #ESMOGuidelines
πBrand new online! #EHA & #ESMO collaborated to bring you this #ClinicalPracticeGuideline on #PTCL. We warmly invite you to read & share with your contacts π bit.ly/PTCL_GL
@myesmo.bsky.social #EHAGuidelines #ESMOGuidelines
πJoin us for the #ESMOGuidelines webinar on #rectalcancer! Don't miss out on expert insights and practical case discussions.
Register now:
π buff.ly/XUlyWOO
π£ESMO #ClinicalPracticeGuideline Express Update on #PancreaticCancer: updated 1st- & #2nd-line treatment recommendations for managing #MetastaticPancreaticCancer, following approval of 1st-line nanoliposomal #irinotecan. #ESMOGuidelines
πhttps://buff.ly/Mybc2Nq
@ducreuxmichel.bsky.social
Proposed treatment algorithm for the management of patients with stage III/IV melanoma according to prior adjuvant treatment received - Amaral et al. Ann Oncol 2024
π₯ Hot off the press!
The most updated #ESMOguidelines on cutaneous melanoma, now out in #AnnOncol. Great to see #TheChristie colleagues @beckilee.bsky.social & Paul Lorigan as co-authors in this panel of esteemed experts π.
π Available #OpenAccess: www.annalsofoncology.org/article/S092...
